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F,-isoprostanes are complex metabolites of arachidonic acid generated via nonenzymatic free 
radical oxidation and are isomeric to prostaglandin Fza, enzymatically produced by 
prostaglandin H, synthase. In theory, four distinct regioisomeric families are possible. These 
regioisomeric families have a common 1,3-diol cyclopentane structural feature, but differ by 
the comparative length of two attached alkyl chains and the position of a third hydroxyl 
group. Eight synthetic PGF,, isomers were found separable by capillary gas chromatography 
(GC) and reversed-phase high-performance liquid chromatography (HPLC). Electrospray 
ionization tandem mass spectrometry was used to detect the elution of these isomers from 
the HPLC column by monitoring the characteristic loss of 44 u (C,H,O) from the 1,3-diol 
cyclopentane ring. Catalytic reduction, derivatization, and electron ionization mass spectro- 
metric techniques were used to obtain definitive information as to the location of the side 
chain hydroxyl position in these isomers through abundant a-cleavage ions. Free radical 
oxidation of arachidonic acid was used to generate a complex mixture of F,-isoprostanes, 
which were separated by HPLC and capillary GC. Members of each of the four specific 
regioisomeric isoprostane families could be identified in this mixture from the predicted 
a-cleavage ions. Although many epimers within a single family type could be separated, the 
four regioisomeric families were substantially superimposed in their HPLC and GC elution. 
The Type I and Type IV regioisomers were the major F,-isoprostane products, but the 
complexity of the isomers required more than a simple GC-mass spectrometry assay to 
precisely identify a particular stereoisomer within a regioisomeric family (e.g., 8-epi-PGF,U). 
Type I F,-isoprostanes are unique noncycloox genase products and may be more specific 
targets to measure lipid peroxidation in vivo. J Am Sot Muss Spectrom 1996, 7, 490-499) Y 
T he formation of oxygen free radical species in biological systems is known to take place by both enzymatic as well as nonenzymatic pro- 
cesses 111. The phospholipid bilayer that surrounds the 
cell serves as an initial barrier for most of the reactive 
species, yet highly reactive species such as hydroxyl 
radical profoundly alter cellular biochemistry as the 
result of lipid peroxidation [2].Lipid peroxidation leads 
to a large number of products, some of which are quite 
simple stable species such as pentane, malonyldialde- 
hyde, and 4-hydroxynonenal [3]. However, recently 
more complex structures have been identified as initial 
oxidation products of lipids. Certain free radical prod- 
ucts of arachidonic acid peroxidation have been ob- 
served that are isomeric to the enzymatically produced 
prostaglandin F, formed by prostaglandin H (PGH) 
synthase [4-71. These isomeric prostaglandins or F,- 
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isoprostanes are formed through a cyclic endoperoxide 
after initial formation of a bisallylic radical site at one 
of three sites in arachidonic acid, namely, at carbon 
atoms 7, 10, or 13. 
Interest in F,-isoprostanes stems not only from the 
similarity of these eicosanoids to the endogenous cy- 
clooxygenase products, but also, as a result of the 
observation, one F,-isoprostane-8-epi-PGF,,-had 
significant biological activity that caused potent con- 
traction of the renal artery of the rat and reduced the 
glomerular filtration rate of the rat kidney [8,9]. There- 
fore, such molecules could play an important role in 
mediation of the biological response to damage caused 
by oxygen free radicals, such as that observed to be 
characteristic of atherosclerosis, ischemic reperfusion 
injury, inflammatory disease, and possibly even cancer 
and aging [lo-121. 
The free radical process involved in the formation 
of the F,-isoprostanes leads to the formation of four 
regioisomers or family subtypes (Scheme I> dependent 
on the initial site of hydrogen atom abstraction from 
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arachidonic acid. Each of the regioisomers consists of a 
mixture of eight racemic diastereoisomers that poten- 
tially yields a total of 64 different F,-isoprostanes pos- 
sible after free radical oxidation of arachidonic acid 
[4, 131. 
The specific assay for F,-isoprostanes has employed 
negative ion chemical ionization gas chromatography 
mass spectrometry (GC/MS) that uses the carboxylate 
anion at m/z 569 to detect the elution of the isomeric 
F,-isoprostanes from the gas chromatographic column 
[14]. Use of this assay with various biological extracts 
typically enables detection of a mixture of isomeric 
compounds as a number of closely eluting compounds 
close to a deuterium-labeled internal standard [5, 151. 
Recently, evidence has been presented for the identifi- 
cation of one specific isomer, 8-epi-PGF,,, which is 
formed by a free radical mechanism based upon four 
separate high-performance liquid chromatography 
(HPLC) purifications followed by capillary gas chro- 
matography (GC) [16]. Although a mixed mass spec- 
trum that contains predicted ions for all four regioiso- 
mers has been previously reported [51, to date no mass 
spectral evidence for the individual regioisomers has 
been reported. 
The four F,-isoprostane regioisomers are struc- 
turally similar in that each contains a cyclopentane 
ring that contains a 13-diol moiety with each hydroxyl 
on the same side of the ring. Two alkyl chains extend 
from the ring: one chain contains the original car- 
boxylic acid moiety of the arachidonic acid and the 
second chain contains the methyl terminus. These iso- 
mers also differ by the position of one additional 
hydroxyl substituent on either of the alkyl chains and 
each family member is uniquely identified by the loca- 
tion of the hydroxyl-containing alkyl chain relative to 
the cyclopentane ring. The enzymatic product of PGH 
synthase action on arachidonic acid results in regioiso- 
mer Type IV with the hydroxyl group at carbon atom 
15. Type I has the hydroxyl substituent at carbon atom 
5; Type II has the hydroxyl substituent at carbon atom 
12; Type III has the hydroxyl substituent at carbon 
atom 8. Mass spectrometric evidence for the formation 
of each of these regioisomer subtypes has been ob- 
tained in detailed studies of the free radical oxidation 
of arachidonic acid described herein. 
Experimental 
Synthetic prostaglandins which include (52, 9a, lla, 
13E, 15s) -9, 11, 15-trihydroxyprosta-5, 13-dien-l-oic 
acid (prostaglandin F2u, PGF,,) and synthetic epimers 
(named as PGF,, derivatives), 8-epi-PGF,,, 5-trans- 
PGF,,, 11 /?-PGF, oi, 15-epi-PGF, u, 9fi-PGF, a, 8-epi-9/3- 
PC+,, 5-trans-9P-PGF,,, [*H418-epi-PGF2., and 
[2HJPGF~,, were purchased from Cayman Chemical 
(Ann Arbor, MI) and used without further purification. 
All solvents used were HPLC grade purchased from 
Fisher Scientific (Fairlawn, NJ). Hydrogen peroxide 
(30%, w/v) and phosphate-buffered saline (PBS) were 
purchased from Sigma Chemical (St. Louis, MO). Cop- 
per (II) chloride, pentafluorobenzyl bromide, diiso- 
propylethylamine, and 5% rhodium absorbed on alu- 
mina powder were purchased from Aldrich Chemical 
(Milwaukee, WI). Bis(trimethylsilyl)trifluoroacetamide 
was purchased from Supelco (Bellefonte, PA). Water 
was purified via a Millipore water ultrafiltration sys- 
tem (Millipore, Bedford, MA). 
Free Radical Oxidation of Arachidonic Acid 
Three micromoles of arachidonic acid (5,8,11,14- 
eicosatetraenoic acid) in 0.01 M sodium hydroxide (100 
PL) was placed in a 15 mL polypropylene conical tube. 
The fatty acid immediately was suspended in 9.7 mL 
of 50 mM PBS, pH 7.3, by vortexing. To the solution, 
H,O, (100 pL) and 1 mM CuCl, (100 pL) were added 
to result in a final concentration of 70 mM and 100 
PM, respectively. The solution was capped and mixed 
gently at 5°C for 8.5 h. Progress of the oxidation was 
monitored by negative ion chemical ionization mass 
spectrometry from aliquots (1%) taken at various time 
points. 
The reaction mixture was loaded onto a C,, (1 mL, 
100 mg) reverse phase 40 PM Bond Elut extraction 
cartridge (Varian, Harbor City, CA). The cartridge was 
preconditioned with 10 mL of methanol followed by 10 
mL of water. The inorganic salts and remaining H,O, 
were eluted with 10 mL water. The isoprostanes and 
other products of arachidonate oxidation were eluted 
with 10 mL methanol and then taken to near dryness 
with rotary evaporation. 
Hydroperoxides or endoperoxides formed during 
the oxidation reaction were reduced with stannous 
chloride to prevent further rearrangement and degra- 
dation of these products. Stannous chloride (3 mM, 1 
mL) was added to the methanol fraction that contained 
oxidized arachidonic acid and allowed to stand for 30 
min at ambient temperature. Water (8 mL) was added 
and the mixture was acidified to pH 3 (1 N HCl). The 
reaction mixture was then subjected to solid phase 
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extraction as before. The oxidized arachidonic acid was 
eluted with 10 mL methanol, the volume was reduced 
in vacua, and solvent was added to yield a final 
volume of 1 mL (9:l water:methanol). 
temperature was held at 400 “C. The collision cell was 
operated with a gas thickness of 172 X 1013 
molecules/cm2 and the orifice potential was typically 
held at -70 V. 
Gas chromatography/mass spectrometry of the 
Reverse Phase High-Performance Liquid 
Chromatography 
An Ultracarb ODS 5 pm, 4.6 mm X 25 cm column 
(Phenomenex, Torrance, CA) was used to separate the 
oxidized arachidonic acid. The mobile phase consisted 
of 0.05% acetic acid adjusted to pH 5.7 with ammo- 
nium hydroxide (system A) and acetonitrile:meth- 
anol (95:5: system B). The separation was carried out 
with a linear gradient starting with 10% B and ramp- 
ing to 100% B in 40 min. The flow rate was 1 mL/min 
and fractions were collected at 0.5 mL/min. 
Devivatization fey Gas Chromatography 
For negative ion chemical ionization GC/MS, a portion 
of the HPLC fractions was derivatized as the pentafluo- 
robenzyl ester trimethylsilyl ethers as described previ- 
ously [ 171. For positive ion electron ionization GC/MS, 
samples were methylated with ethereal diazomethane 
and then hydrogenated by bubbling hydrogen gas 
through a methanol solution of the sample for 20-30 
min after the addition of Rh/Al,O, (1 mg) as catalyst. 
Samples were then taken to dryness and derivatized as 
the trimethylsilyl ethers by using bis(trimethylsilyl)tri- 
fluoroacetamide (20 PL) and injected directly onto the 
gas chromatographic column in the derivatization mix- 
ture, which contained an equal volume of acetonitrile. 
Mass Spectrometvy 
On line HPLC analysis of the F,-isoprostanes was 
performed in the negative ion mode by utilizing the 
multiple reaction monitoring mode of the Sciex API- 
III+ triple quadrupole mass spectrometer (Perkin- 
Elmer Sciex, Thornhill, Canada) to monitor the loss of 
44 u from the carboxylate anion. The HPLC was oper- 
ated at a flow rate of 1 mL/min with a linear gradient 
of 25-50% B over 25 min and a postcolumn split that 
yielded 15 pL/min flow into the mass spectrometer. 
The remaining 985 pL/min was collected by using a 
fraction collector operated at 0.25 mL/min. The elution 
of each component relative to the retention time (t,) 
for J2H,18-epi-PGF,, and [‘Hq]PGF2. mixed with the 
samples was calculated by the following equation for 
relative retention index @RI): 
HPLC fractions was-carried out in both the electron 
capture negative ion mode and by electron ionization 
via either a Finnigan SSQ or a TSQ-700 mass spectrom- 
eter (Finnigan-MAT, San Jose, CA). Both instruments 
were interfaced with a capillary DB-1 column (15 m X 
0.25 mm: J&W Scientific, Folsom, CA) with a 0.25 u 
film thickness. The injector temperature was main- 
tained at 275 “C and the transfer line at 300 “C. For 
electron capture negative ionization mass spectrometry 
the instrument was maintained with an ion source 
pressure of approximately 1 mtorr with methane. The 
F,-isoprostanes were detected by using selected ion 
monitoring of the ion at m/z 569, which corresponded 
to the loss of pentafluorobenzyl radical from the intact 
F,-isoprostane anion. The corresponding ion for either 
deuterium-labeled PGF,, or 8-epi-PGF,, was m/z 573, 
and these two molecules were well separated by gas 
chromatography. Electron ionization mass spectra were 
recorded at 70 eV; the instrument was scanned over a 
mass range of 50-600 u/s. The ion source temperature 
was maintained at 180 “C. 
Gas chromatographic retention is expressed as 
equivalent fatty acid ester carbon number, determined 
as previously described for either the pentafluoroben- 
zyl or methyl esters [18]. 
Results 
Synthetic prostaglandins epimeric to the PGF,, Type 
IV regioisomer were partially separated by reversed 
phase HPLC (Figure 1). These epimeric prostaglandins 
were detected as they eluted from the HPLC by colli- 
LC/MS/MS 
P 
1 
B 
19.2 Dg 8-epi-PGFza D4PGFza 
m/z 357 -313 
t, unknown - tR[2H,]8-cppi-PGF,, Retention time (min) 
RR1 = 
tpJ2HJPGF2. - t,[2H,]8-epi-PGF,, 
+ 1 (1) Figure 1. Direct liquid chromatography tandem mass spectrom- 
etry analysis via electrospray ionization of a mixture of synthetic 
Type IV regioisomers of PGF,, separated by reversed-phase 
For all electrospray ionization analyses, the curtain gas HPLC. (a) The loss of 44 u (C,H,O) from the carboxylate anion 
flow rate was 1.2 L/min, nebulizer pressure was 42 
(m/z 353) was used to detect the elution of each synthetic 
isomer. Cb) The loss of 44 u from m/z 357 was used to detect the 
lb/in’, turbospray flow was 6 L/min, and turbospray elution of the deuterium-labeled internal standards. 
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sion-induced dissociation of the carboxylate anions 
formed by electrospray ionization with loss of C,H,O 
(4.4 u> as described previously for the characteristic 
decomposition ions observed for PGF,, [ 191. Elution of 
these synthetic compounds occurred between 12 and 
17 min: 8-epi-PGF,, eluted in the earliest peaks and 
PGF,, eluted last. The elution of these two species also 
was marked by the deuterium-labeled internal stan- 
dards [ 2H,]8-epi-PGF2, and [2H41PGF2, at 13.55 and 
16.37 min, respectively (Figure lb). The relative reten- 
tion characteristics for each of the epimeric prosta- 
glandins relative to [ ‘H,]PGFz, in this reversed phase 
system are presented in Table 1. 
Gas chromatographic separation of the epimeric 
prostaglandins was carried out after conversion either 
to the pentafluorobenzyl (PFB) ester trimethylsilyl 
(TMS) ether or methyl ester trimethylsilyl ether deriva- 
tives. The former derivative was used for a sensitive 
negative ion GC/MS assay whereas the latter deriva- 
tive was used for positive ion electron ionization mass 
spectrometric analysis. Partial separation of each of the 
Type IV regioisomers epimeric to PGFzu was achieved 
as the PFB/TMS derivative (Figure 2a) and, as ex- 
pected, the elution order of each individual epimer 
was different from that observed for the HPLC separa- 
tion (Table 1). Derivatized 8-t@- PGF,. did elute prior 
to PGF,,; however, there was no obvious structural 
determinant to the elution order of each epimer. 
Because the last component to elute had a double 
bond at C-5 of the trans configuration, but was other- 
wise identical to the next to last component of the 
mixture to elute, namely PGF,,, this suggested that 
the geometry of each double bond played an important 
role in determination of the gas chromatographic re- 
tention behavior in this set of isomeric molecules. 
Catalytic reduction of the epimeric PGF,, standards 
Table 1. Relative retention indices of synthetic 
prostaglandins and F,-isoprostanes Type IV 
Epimers 
F,-isoprostane relative HPLC retention 
retention indexa timeb (min) 
[2H,18-epi-PGF2, 1 .oo 13.55 
[~HJPGF,, 2.00 16.37 
5-trans-9P-PGF,, 0.89 13.25 
8-epi-9P-PGF,, 1 .oo 13.55 
8-epi-PGF,, 1 .oo 13.55 
9P-PGF,, 1.07 13.75 
1 IP-PGF,, 1.39 14.65 
5-trans-PGF,, 1.71 15.55 
15-epi-PGF,, 1.71 15.55 
“GF,, 2.00 16.37 
aElution of F,-isoprostane relative to [*H,]8-epi-PGF,, and 
[*H,lPGF,, according to the equation given in Experimental Proce- 
dures. 
bOn-line reversed-phase HPLC analysis monitored with a Sciex 
API-Ill+ triple quadrupole mass spectrometer. HPLC was operated 
at a flow rate of 1 mL/min with a linear gradient of 25-50% B 
(A= pH 5.7 H,O. 0.05% CH,CO,H; B = 95:5, CH,CN:MeOH) and a 
postcolumn split that yielded 15 mL/min flow into the mass spec- 
trometer. 
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Figure 2. (a) GC/MS analysis via electron capture ionization of 
the pentafluorobenzyl trimethylsilyl ether derivatives of the syn- 
thetic eplmeric PGF,, Type IV regioisomers. The carboxylate 
anion at M/Z 569 was used in selected ion monitoring mode to 
detect the elution of the components in the mixture. The elution 
is expressed as equivalent fatty acid carbon number (PFB ester). 
(b) GC/MS analysis via electron ionization of catalytically re- 
duced methyl ester trimethylsilyl ether derivative of the Type IV 
regioisomers epimeric to PGF’,,. The ion at m/z 498 (M-90) was 
used to monitor the elution of the epimers. The retention time is 
expressed as equivalent fatty acid carbon number (methyl ester). 
followed by gas chromatographic separation of the 
methyl ester trimethylsilyl ether derivative simplified 
to some extent the separations of individual isomers 
by reducing the total number of isomers present and 
affecting separation of the 9/3-PGF,, from the 8-epi- 
PGF,, and 8-epi-9P-PGF,, epimers (Figure 2b). For the 
fully saturated compounds, the earliest eluting epimer 
had adjacent substituents of the cyclopentane ring trans 
to each other, whereas the last eluting epimers had 
three substituents on the same (Y side of the cyclopen- 
tane ring. 
The combination of HPLC and gas chromatographic 
separation could effect resolution of most of the avail- 
able epimeric PGF,, Type IV regioisomers. For exam- 
ple, separation of 5-truns-PGF,. and 15-epi-PGF,, was 
not possible by reversed phase HPLC (Table 1); how- 
ever, they were well separated by gas chromatography 
(Table 2). PGF,, was well separated from 15-epi-PGF,. 
by HPLC, but both co-eluted in capillary GC (Table 2) 
either as the reduced or nonreduced molecules. Some 
epimers could not be separated by either technique 
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Table 2. Gas chromatographic equivalent carbon number9 
of synthetic Type IV F,-isoprostaneb loo 
PFB/TMs equivalent CH,/TMS equivalent 
carbon numberC 
carbon numberd 
Epimers Unreduced Reduced Reduced 
So-PGF,, 23.05 23.45 23.80 
5-trans-Sp-PGF,, 23.12 23.45 23.80 
8-epi-PGF,, 23.04 23.60 23.90 
8-epi-9P-PGF,, 23.04 23.60 23.90 
1 lP-PGF,, 23.32 23.86 24.20 
1 5-epi-PGF,, 23.44 23.97 24.30 
PGF,, 23.44 23.97 24.30 
5-trans-PGF,, 23.69 23.97 24.30 
217 
PGF2a 
355 
1.8 I. 
aEquivalent carbon numbers were calculated by using the corre- 
sponding fatty acid derivatives according to the method previously 
described fief 17). 
bThese standards were derivatized as pentafluorobenzyl ester 
trimethylsilyl ethers or catalytically reduced with Rh/AI,Os and H, 
gas prior to derivatization as PFB ester TMS ethers or methyl ester 
TMS ethers. 
‘Electron capture negative ion chemical ionization mass spec- 
trometry. Operating parameters are as described in Experimental 
Procedures and a linear temperature program of 230 -235 “C in 10 
min. 
dElectron ionization mass spectrometry. Operating parameters 
are as described in Experimental Procedures and a linear tempera- 
ture program of 210-215 “C in 10 min. 
IdO 200 300 400 500 600 
m/z 
Figure 3. Electron ionization mass spectrum (70 eV) of the 
reduced methyl ester trimethylsilyl ether derivative of authentic 
PGF, a. Abundant a-cleavage ions are indicated. 
(Figure 3) was virtually identical for all of the reduced 
Type IV regioisomers (data not shown). 
(such as S-epi-PGF,, from 8-epi-9@PGF,,), yet a 30 m 
capillary GC column was reported to achieve this 
separation [20]. However, this latter compound would 
not be an expected F,-isoprostane, which requires the 
1,3-diol substituents to be on the same side of the 
cyclopentane ring. 
Electron Ionization Mass Spectrometry 
Abundant formation of a-cleavage ions adjacent to 
the trimethylsiloxyl substituent in the side chain would 
be expected to occur for each of the different regioiso- 
mers of F,-isoprostanes. Those a-cleavage ions that 
retained the cyclopentane ring would appear at the 
mass that corresponds to a further loss of trimethylsi- 
lanol. Because the hydroxyl substituent on the alkyl 
portion of the F,-isoprostane is unique for each of the 
regioisomers (Scheme I), such u-cleavage ions pre- 
dicted in Figure 4 would uniquely identify each of the 
four regioisomers present in a complex mixture such 
as would be expected from a free radical oxidation of 
arachidonic acid. 
Reduction of the prostaglandins (each of which con- 
tains two double bonds) simplified the chromate 
graphic separation of the individual Type IV epimers 
and furthermore altered the mass spectrometric behav- 
ior when analyzed by electron ionization techniques 
(EI). The EI mass spectrum of reduced PGF,, is pre- 
sented in Figure 3 and was characterized by a series of 
rx-cleavage ions adjacent to the 15-trimethylsiloxy sub- 
stituent. The ion at m/z 173 corresponded to ol-clea- 
vage of the 14,15-bond and the ion at m/z 427 
corresponded to a-cleavage on the other side of the 
trimethylsiloxy moiety with the concomitant loss of 
trimethylsilanol. Either ion could be directly formed 
from the observed ion at m/z 498, which corre- 
sponded to the loss of trimethylsilanol from the molec- 
ular ion (m/z 588). The ions m/z 73, 191, and 217 
were characteristic of trimethylsilylated polyhydric 
molecules, in particular m/z 217, which is quite abun- 
dant for those compounds that contain a 1,3 diol struc- 
ture [21]. The ion at m/z 355 corresponded to cleavage 
of the alkyl chain adjacent the cyclopentane ring 
(carbon-g) and loss of trimethylsilanol. This was sup- 
ported by experiments with d,-TMS-labeled reduced 
PGF,,. The EI mass spectrum of derivatized PGF,, 
Arachidonic Acid Oxidization 
Oxidation of arachidonic acid was carried out by using 
a modified Fenton reaction with CuCl, and H,O, to 
generate hydroxyl radical and induce peroxidation [22]. 
397 Type II 
267 203 397 
Type ZIZ 
225 245 35.5 
Type IV 
35.5 
T.+fW t-90 
Figure 4. Predicted u-cleavage ions for each of the four F,-iso- 
prostane regioisomeric families. The dashed lines indicate un- 
known stereochemistry. 
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Following oxidation, products were isolated by using 73, 191, and 217. Furthermore, abundant ions were 
reversed phase HPLC and individual HPLC fractions observed at m/z 203 and 397, the expected a-cleavage 
were screened for the appearance of F,-isoprostanes by ions. Additional abundant ions were also present at 
using negative ion chemical ionization GC/MS of the m/z 385 and 408. The ion at m/z 385 could corre- 
pentafluorobenzyl ester trimethylsilyl ether derivative spond to an u-cleavage of the M-90 ion species with 
(m/z 569). Those HPLC fractions that contained F,-iso- charge retention at carbon-6, but is most likely the 
prostanes then were reduced catalytically and deriva- cleavage of the alkyl chain adjacent to the cyclopen- 
tized to the methyl ester trimethylsilyl ether for elec- tane ring (carbon-12) and loss of trimethylsilanol as 
tron ionization GC/MS. Mass chromatograms for the observed for reduced PGF,,. The ion at m/z 408 
expected a-cleavage ions for each subtype revealed would be loss of one additional trimethylsilanol from 
those HPLC fractions that contained each of the four m/z 498. This oxidation product of arachidonic acid 
F,-isoprostane regioisomers. was consistent with a Type I F,-isoprostane. 
Type I F,-isoprostanes would be expected to yield A Type II regioisomer would have the side chain 
a-cleavage ions at m/z 203 and m/z 397 (an a-clea- hydroxyl group at carbon-12 that would yield two 
vage ion from the M-90). The inset to Figure 5a shows abundant a-cleavage ions at m/z 215 and 385. Indi- 
the mass chromatogram for these target ions that re- vidual F,-isoprostanes of this family member were 
veals the elution of a component from the gas chro- substantially less abundant than either Type I or Type 
matograph with a carbon number of 23.80. The mass IV family members, but, nevertheless, it was possible 
spectrum of this component was consistent with an to obtain a representative mass spectrum of this family 
F,-isoprostane as evidenced by the observed ion at subtype as seen in Figure 5b for a component that 
m/z 498 (M-90) and the trimethylsiloxyl ions at m/z eluted from the HPLC in 22 min and a carbon number 
a 
100 
203 
2 
I 
‘17 
217 
m/z 
245 
P a 
191 427 
147 
129 
498 
100 200 300 400 SW 600 I00 200 300 400 500 600 
m/Z m/Z 
217 
215 \ 
397 TYPe II 
295 147 205 
I29 ' 191 
\ 
268 385 408 
‘17 
355 Twe IV 
355 
Figure 5. Electron ionization mass spectrum of reduced methyl ester trimethylsilyl ether derivative of F,-isoprostane regioisomeric 
families obtained by free radical oxidation (modified Fenton reaction) of arachidonic acid. (a) Type I F,-isoprostane component that 
displays abundant o-cleavage ions at m/z 203 and 397. The inset to a shows the selected ion monitoring trace for these o-cleavage ions 
that indicates the elution of this component at scan number 70 presented as a. (b) Type II F,-isoprostane that displays abundant 
a-cleavage ions at m/z 215 and 385. (c) Type III F,-isoprostane that displays abundant o-cleavage ions at m/z 245 and 355. Cd) Type 
IV F,-isoprostane that displays abundant a-cleavage ions at m/z 173 and 427. Dashed lines in the chemical structures are used to 
indicate unknown stereochemistry. 
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of 24.17 by gas chromatography. The expected ions for 
derivatized F,-isoprostane were present at m/z 73, 
129, 147, 191, 217, 408 (M-2TMSOH), and 498 (M- 
TMSOH) [23]. The additional ion at m/z 295 was most 
likely a further loss of trimethylsilanol from the 01- 
cleavage ion at m/z 385 because this ion would retain 
the cyclopentane ring and associated trimethylsiloxyl 
groups, 
The isoprostane family member Type III would be 
characterized by a hydroxyl group at carbon-8 in the 
alkyl chain and a-cleavage ions at m/z 245 and 355 
would be expected for the reduced, derivatized prod- 
uct. The HPLC fraction at 20.5 min contained such a 
Type III F,-isoprostane as evidenced by a component 
that eluted from the gas chromatograph as the methyl 
ester trimethylsilyl ether with a carbon number of 
24.00 that yielded abundant ions at m/z 245 and 355. 
The observed ion at m/z 427 likely corresponded to 
cleavage adjacent to the cyclopentane ring at carbon-15 
with loss of trimethylsilanol. Type III family members 
were also of lesser abundance than either Type I or 
Type IV F,-isoprostanes. 
Figure 5d shows a mass spectrum of one Type IV 
F,-isoprostane that eluted from the HPLC in the frac- 
tion collected at 20 min and exhibited a gas chromato- 
graphic retention carbon number of 23.90 as the 
reduced trimethylsilyl methyl ester derivative. The ob- 
served mass spectrum was virtually identical to that of 
authentic PGF,, (Figure 3) and the carbon number was 
identical to 8-epi-PGF,.. Several other Type IV family 
members were readily identified in this mixture of 
oxidized arachidonic acid, and Type I and Type IV 
F,-isoprostanes were the most abundant species formed 
in this model system of lipid peroxidation. 
Liquid Chromatography-Mass Spectrometvy 
Analysis 
Limited oxidation of arachidonic acid by using the 
modified Fenton reaction (4 h) yielded a complex mix- 
ture of products that were analyzed by direct liquid 
chromatography-electrospray tandem mass spectrom- 
etry (ESI-MS/MS) after extraction of the oxidized sam- 
ple and reduction of peroxy and hydroperoxy groups 
with SnCl,. Two deuterated standards, [‘H,]8-epi- 
PGF,, and [ ‘H,lPGF,,, were added to serve as HPLC 
retention standards. Fractions were collected from a 
split of the HPLC effluent prior to electrospray and 
were analyzed off-line by electron ionization GC/MS 
as the reduced trimethylsilylated methyl ester prod- 
ucts. The F,-isoprostanes that eluted from the HPLC 
were detected by loss of 44 u (C,H,O) from m/z 353 
(m/z 353 + 309) and m/z 357 (m/z 357 + 313) for 
the deuterium-labeled internal standards as seen in 
Figure 6. Multiple components were obvious for the 
F,-isoprostanes (m/z 353 + 309) whereas the epimeric 
deuterated internal standards were clearly separated 
as single peaks; therefore, each collected fraction was 
likely to contain unresolved epimeric F,-isoprostanes. 
LUMVMS 1 
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I 
B 
Dq 8-epi-PGF2a 
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m/z 357 -313 
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5 10 15 20 2.5 
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Figure 6. Direct liquid chromatography-tandem mass spec- 
trometry analysis obtained by electrospray ionization for the loss 
of 44 u from the carboxylate anion of F,-isoprostanes (m/z 353). 
The F2-isoprostanes were obtained by free radical oxidation 
(modified Fenton reaction) of arachidonic acid. (a) Fractions col- 
lected during the elution of the isoprostanes indicated by the 
numbers 1-4 were collected and analyzed by electron ionization 
after catalytic reduction and derivatization. The regioisomeric 
families identified in these fractions are indicated in Table 3. fb) 
A loss of 44 u from m/z 357 that corresponds to the deuterium- 
labeled internal standards. 
Catalytic reduction and EI GC/MS analysis enabled 
assignment of the major F,-isoprostane family subtype. 
The HPLC fractions collected at peaks 1, 2, 3, and 4 
from 15 to 20 min contained several distinct, deriva- 
tized F,-isoprostanes separated by the gas chromato- 
graph, but only major epimers could be assigned un- 
ambiguously to one of the four regioisomer types 
(Table 3). The HPLC fractions collected between 15 
and 16 min contained a F,-isoprostane based on the 
ions at m/z 498,217,191, and 73 in the most abundant 
GC component. The a-cleavage ions at m/z 173 and 
427 as well as an abundant ion at m/z 355 were 
consistent with a Type IV regioisomer. It is important 
to note, however, that the gas chromatographic carbon 
number of 23.90 (Table 3) was identical to that of the 
catalytically reduced authentic 8-epi-PGF,. (Table 2); 
however, the HPLC RR1 (1.74; Table 3) of this compo- 
nent was significantly different from that of 8-epi-PGF,, 
(RR1 1.00; Table 1). Thus, this component was an 
entirely different stereoisomer of the Type IV family 
than either 8-epi-PGF,, or PGF,,. The HPLC fractions 
that eluted between 16.7 and 17.9 min contained one 
Type I and two Type IV regioisomers with carbon 
numbers of 23.80, 23.90, and 24.13, respectively. All of 
the common F,-isoprostane ions at m/z 498, 217, 191, 
and 73 were present with the Type I regioisomer 
identified by the characteristic a-cleavage ions at m/z 
203 and 397 (e.g., Figure 5a). The Type-IV isomers 
displayed the characteristic a-cleavage ions seen in 
Figures 3 and 5d. The fractions from the HPLC be- 
tween 18 and 18.7 min displayed mass spectra consis- 
tent with regioisomers of the Type IV (carbon number 
24.13) and Type I families (carbon number 24.23) as 
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Table 3. Relative retention indices, gas chromatographic carbon numbers and regioisomeric 
family types formed by free radical oxidation of arachidonic acid.” 
HPLC HPLC retention CHJTMS equivalent Major regioisomeric 
fractionsb RRIC time (min)” carbon numberd,e family type 
1 1.74 15.65 23.90 IV 
2 2.22 17.00 23.80 I 
23.90 IV 
24.13 IV 
3 2.71 18.36 24.13 IV 
24.23 I 
24.30 IV 
4 3.06 19.35 24.20 I 
24.23 IV 
24.30 IV 
aThese F,-isoprostanes were formed by Cu2f/H,0, oxidation of 5.8.1 1.14.eicosatetraenoic acid and 
separated by reversed-phase HPLC prior to catalytic reduction and derivatization as methyl ester TMS 
ethers. 
%ee Figure 6. 
‘Elution of F,-isoprostane relative to [‘H,l8-epi-PGF>, and [*H,]PGF,, according to the equation 
given in Experimental Procedures. On-line reversed-phase HPLC analysis monitored with a Sciex 
API-III+ triple quadrupole mass spectrometer. HPLC was operated at a flow rate of 1 mL/min with a 
linear gradient of 2550% 6 (A= pH 5.7 H,O. 0.05% CH,CO,H; 8= 95:5, CH,CN:MeOH) and a 
postcolumn split that yielded 15 mL/min flow into the mass spectrometer. 
dElectron ionization mass spectrometry. Operating parameters as described in Experimental Proce- 
dures and a linear temperature program of 210-215 “C in 10 min. 
eEquivalent carbon numbers were calculated by using the corresponding fatty acid derivatives 
according to the method previously described (ref. 17). 
well as a Type IV regioisomer (carbon number 24.30). 
This latter Type IV regioisomer had the same gas 
chromatographic retention time as PGF,,; however, its 
HPLC elution RRI (2.71; Table 3) was not the same as 
any of the specific epimers available for study (Table 
1). Type I (carbon number 24.20) and Type IV (carbon 
numbers 24.23 and 24.30) regioisomers were identified 
as the major components present in the HPLC fractions 
that eluted between 18.8 and 19.8 min (Table 3). Multi- 
ple F,-isoprostanes were present in other HPLC frac- 
tions at an abundance that precluded definitive assign- 
ment of the elution of Type II or Type III regioisomers. 
The deuterium-labeled prostaglandins did co-elute in 
the fractions where Type-IV F,-isoprostanes that eluted 
between 13 and 14 min ([2H,18-e@-PGF,,> and 16-17 
min ([2~,]PG~,,, as seen in Figure 61 were identified. 
Discussion 
Isoprostanes are a relatively recent addition to the 
family of lipid mediators that are derived from arachi- 
donic acid by a free radical mechanism of oxidation 
and lead to a family of regioisomers each composed of 
multiple epimers rather than enzymatic products of 
arachidonate oxidation. Thus a complex mixture of 
isoprostanes results in tissues as a consequence of the 
reaction of active oxygen species with arachidonate 
esterified to membrane glycerophospholipids. Nega- 
tive ion electron capture mass spectrometry has been 
instrumental in identification of the existence of 
epimeric isoprostanes since the pioneering work of 
Roberts and colleagues [4-9, 13-161. Continued inter- 
est in these molecules stems in part from the biological 
activity that has been discovered for one of the prod- 
ucts, namely, 8-epi-PGFz, [8, 91. The activity of this 
molecule has led to the suggestion that these free 
radical products may play an important pathophysio 
logical role to mediate the events of tissue damage 
caused by active oxygen species [ 13, 141. Measurement 
of isoprostanes also has been suggested to serve as a 
reliable marker of oxidant injury in vivo [g-lo]. 8-E@- 
PGF,, also has been uniquely identified as one of the 
free radical products through an exhaustive isolation 
procedure that involved multiple HPLC as well as 
capillary gas chromatographic separations [ 161. Re- 
cently, evidence also has emerged to suggest that 8-e@- 
PGF,, can be a cyclooxygenase product also, which 
thus suggests that measurement of this isoprostane 
may not truly reflect noncylooxygenase formation of 
isoprostanes [24]. However, in experiments that used a 
specific immunoassay, activation of platelet cyclooxy- 
genase did not lead to a correlation between produc- 
tion of 8-epi-PGF,, and PGF,, [25] which suggests that 
8-epi-PGF,, formation was independent of platelet cy- 
clooxygenase activity. However, 8-epi-PGF,, is a mem- 
ber of the same regioisomeric family as native PGF,, 
(Type IV)-the enzymatic product of PGH 
synthase-and the search for other regioisomeric fam- 
ily members of isoprostanes has continued. 
Separation of most synthetic epimers of PGF,, was 
possible both by reversed-phase HPLC as well as by 
capillary gas chromatography. Unfortunately, the 
availability of only a small number of PGF2, epimers 
precluded definite conclusions as to unique retention 
properties of the Type IV regioisomer family. Never- 
theless, there was a trend to suggest that an all trans 
arrangement of the substituents or a cis (e.g. “8-e@“> 
arrangement of the unsaturated alkyl substituents of 
498 WAUGH AND MURPHY J Am Sac Mass Spectrom 1996,7,490-499 
the cyclopentane ring did impart early elution from 
both HPLC and GC. Furthermore, the trans configura- 
tion of the double bond at the 5-position and the trans 
arrangement of the alkyl substituents on the cyclo- 
propane ring (adjacent to the 1,3-dial) had the effect of 
increasing gas chromatographic retention time whilst 
decreasing HPLC retention time. 
Electrospray ionization tandem mass spectrometry 
was found to be a sensitive method with which to 
detect the elution of F,-isoprostanes from an HPLC 
chromatographic column. Because these molecules do 
not have a favorable UV chromophore (two isolated 
double bonds), sensitive detection of these molecules 
that elute from an HPLC is not possible, in particular 
at the sensitivities required for measurement of these 
molecules present in biological tissues. However, elec- 
trospray mass spectrometry generated abundant car- 
boxylate anions at m/z 353 (for all regioisomeric F,- 
isoprostanes) that further decomposed by the loss of 
C,H,O (44 u) following collisional activation in the 
rf-only quadrupole of the collision cell. Although this 
loss of 44 u is potentially identical to a loss of CO, 
from a carboxylate anion, it is particularly abundant 
for the isoprostanes that have a 1,3 cyclic diol struc- 
ture. This collision-induced process has been described 
previously for prostaglandins and thromboxanes, 
which share this common structural modality [19, 261. 
Definitive information as to the specific regioiso- 
merit family was obtained by using electron ionization 
mass spectrometry of the reduced isoprostanes. Satura- 
tion of the two double bonds in these molecules de- 
creased the total number of epimers in the complex 
mixture. This step did result in a loss of information 
with regard to the geometry of the two remaining 
double bonds; however, an increase in specific mass 
spectrometric fragmentation was observed, in particu- 
lar cleavage adjacent to the hydroxyl group of the 
alkyl side chain. These a-cleavage ions as well as 
a-cleavage ions with the concomitant loss of trimethyl- 
silanol proved to be the most abundant ions for each of 
the Type IV regioisomers epimeric to PGF,, studied. 
Because all reduced epimers of PGF,, gave identical 
EI mass spectra (with characteristic m-cleavage ions), 
all unknown epimers within a given regioisomer type 
would be expected to yield identical EI spectra (with 
the predicted characteristic a-cleavage ions). Thus, 
monitoring of characteristic a-cleavage ions of the 
reduced isoprostanes (after partial separation by HPLC) 
would be a strategy to uniquely identify compounds 
in complex mixtures that belong to each regioisomer 
type (by GC/MS after HPLC purification), but their EI 
mass spectra alone would not uniquely identify spe- 
cific members within a family. 
Free radical oxidation of arachidonic acid yields a 
complex mixture of isoprostanes as revealed by elec- 
trospray tandem mass spectrometry and the elution of 
multiple components that correspond to arachidonic 
acid with three oxygen atoms and four rings or double 
bonds (m/z 353). The detection of these isoprostanes 
that elute from the HPLC chromatograph was made 
possible by collisional activation of m/z 353 and obser- 
vation of m/z 309 that corresponds to the loss of 
C,H,O. Those fractions identified by tandem electro- 
spray mass spectrometry were then catalytically re- 
duced and derivatized for electron ionization mass 
spectrometry-capillary gas chromatography. Use of 
this approach enabled the four specific regioisomeric 
families of isoprostanes to be identified by using the 
specific a-cleavage ions for the alkyl-chain hydroxy 
groups present in each of the F,-isoprostanes. Each of 
the mass spectra were interpreted in terms of the 
unique isoprostane family subtype. 
Type I and Type IV regioisomeric compounds could 
be readily identified by using this process because of 
their abundance in the oxidation mixture. However, it 
was more difficult to unambiguously detect the spe- 
cific family subtypes II and III, which suggests that 
they were produced in substantially lower quantities. 
This is not surprising based upon the mechanism of 
formation of each of the regioisomeric families. Initial 
radical localization at carbon-7 can lead to only one 
class of isoprostane, namely, the Type I family. If 
oxygen is attached to carbon atom 5 from this carbon-7 
radical species, a different family of oxidized arachi- 
donic acid would be formed that includes 5-hydroper- 
oxyeicosatetraenoic acid (5-HPETE) and the 
isoleukotriene family [27]. The same is true for the 
initial radical attack at carbon-13, which could only 
lead to regioisomeric family subtype IV and 15-HPETE. 
Free radical attack at carbon-10 would lead to two 
different isoprostane families, Type II and Type III, as 
well as B-HPETE and 12-HPETE. Thus it is not surpris- 
ing that the Type II and Type III regioisomeric iso- 
prostanes were of lower abundance than those of Type 
I and Type IV. It is important to note that more than a 
simple GC/MS assay is necessary to precisely identify 
a particular stereoisomer within a regioisomeric fam- 
ily, for example B-epi-PGF,, as shown by the foregoing 
liquid chromatography-mass spectrometry analysis 
when epimers with the same GC carbon number are 
separable by HPLC. Nevertheless, results of these 
studies revealed the elution of all four regioisomeric 
families at very similar conditions of reversed-phase 
HPLC and capillary gas chromatography. 
It has been suggested that measurement of iso- 
prostanes may serve as a noninvasive marker of the 
initial events of lipid peroxidation, rather than the 
extensive breakdown products of 4-hydroxy nonenal 
or malonyldialdehyde [13, 141. The results of these 
studies suggest that development of a specific assay 
for isoprostanes based upon either mass spectrometric 
techniques or, even more critically, immunoassays that 
recognize unique structural characteristics, might be 
best for the Type I regioisomeric isoprostane family 
subtype. One reason for this is the other abundant 
isoprostane regioisomer Type IV is identical in cy- 
clopentane ring and hydroxyl group position to that 
obtained following the action of PGH synthase on 
J Am Sot Mass Spectrom 1996, 7, 490-499 F,-ISOPROSTANES FROM ARACHIDONIC ACID 499 
arachidonic acid. This immunological cross-reactivity 
with endogenous prostaglandin and prostacyclin 
metabolites may be expected for antibodies directed 
against the Type IV structural isotopes. Although the 
biologically active 8-epi-PGF,, isoprostane has been 
targeted for both direct mass spectrometric as well as 
immunoassay techniques, the 8-epi-PGF,, target is 
largely based upon current commercial availability of 
this isomer, but measurement of this isoprostane is 
confounded by the recent finding of 8-epi-PGF,, as a 
PGH synthase-derived product [23]. The regioisomeric 
family Type I is not derived from PGH synthase and 
thus would represent a totally novel structure for 
which specific assays could be developed. 
Acknowledgments 
This work was supported in part by a grant from the National 
Institutes of Health (HL34303). 
References 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
Pryor, W. A. Ann. Rev. Physiol. 1986, 48, 657-667. 
Halliwell, B.; Gutteridge, J. M. C. In Free Rndicnls in Biology 
and Medicine. Oxford University Press: Oxford, UK, 1989. 
Shimizu, T.; Kondo, K.; Hayaishi, 0. Arch. Biochem. Biopkys. 
1989, 206,271-279. 
Morrow, J. D.; Harris, T. M.; Roberts, L. J., II. Ana!. Biockem. 
1990, 284,1-10. 
Morrow, J. D.; Hill, K. E.; Burk, R. F.; Nammour, T. M.; Badr, 
K. F.; Roberts, L. J., II. PVOC. N&l. Acnd. Sci. U.S. A. 1990 87, 
9383. 
Morrow, J. D.; Minton, T. A.; Mukundan, C. R.; Campbell, 
M. D.; Zackert, W. E.; Daniel, V. C.; Badr, K. F.; Blair, I. A.; 
Roberts, L. J., II. 1. Biol. Ckem. 1994, 269, 4317-4326. 
Morrow, J. D.; Awad, J. A.; Kato, T.; Takahashi, K.; Badr, 
K. F.; Roberts, L. J., II; Burk, R. F. 1. Clin. Invest. 1994, 90, 
2502-2507. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
Morrow, J. D.; Minton, T. A.; Roberts, L. J., II. Prostagkmdins. 
1992, 44,155-163. 
Takahashi, K.; Nammour, T. M.; Fukunaga, M.; Ebert, J.; 
Morrow, J. D.; Roberts, L. J., II; Hoover, R. L.; Badr, K. F. J. 
Clin. Invest. 1992, 29, 136-141. 
Kennedy, T. I’.; Rao, N. V.; Hopkins, C.; Pennington, L.; 
Tolley, E.; Hoidal, J. R. I. Clin. Invest. 1989, 83, 1326-1335. 
Tarr, M.; Samson, F., Eds. Oxygen Free Radicals in Tissue 
Injury. Birkhauser: Boston, 1993. 
Warren, J. S.; Ward, I’. A.; Johnson, K. J. In Mediators of the 
Infummatory Process; Henson, I’. M.; Murphy, R. C., Eds.; 
Elsevier: Amsterdam, 1989; p 159. 
Roberts, L. J., II; Morrow, J. D. Adv. Prostugkmdin, Tkuombox- 
ane, Leukotriene Res. 1995, 23, 219. 
Morrow, J. D.; Roberts, L. J., II. Methods Enzymol. 1994, 233, 
163-175. 
Morrow, J. D.; Roberts, L. J., II. Free Radical Bio/. Med. 1991, 
10,195-200. 
Morrow, J. D.; Minton, T. A.; Badr, K. F.; Roberts, L. J., II. 
Biochim. Biophys. Acta. 1994, 1210, 244248. 
Wheelan, I’.; Zirrolli, J. A.; Murphy, R. C. J. Am. Sot. Muss 
Spectrom. 1995, 6, 40-51. 
Sala, A.; Voelkel, N.; Maclouf, J.; Murphy, R. C. J. Biol. Chem. 
1995, 265,21771-21778. 
Zirrolli, J. A.; Davoli, E.; Bettazzoli, L.; Gross, M. L.; Murphy, 
R. C. J. Am. Sot. Mass. Spectrom. 1990, 1, 325-335. . 
20. Gopaul, N. K.; Angg%rd, E. E.; Mallet, A. I.; Betteridge, D. J.; 
Wolff, S. I’.; Nourooz-Zadeh, J. FEBS Lett. 1995, 368, 225-229. 
21. Draffan, G. H.; Stillwell, R. N.; McCloskey, J. A. Org. Mass 
Spectrom. 1968, 1, 669. 
22. Halliwell, B.; Gutteridge, J. M. Biockem. J. 1984, 219, l-14. 
23. Murphy, R. C. In The Handbook of Lipid Research. Plenum 
Press: New York, 1993. 
24. Pratico, D.; Lawson, J. A.; FitzGerald, G. A. J. Biol. Ckem. 
1995, 270,9800-9808. 
25. Ciabattoni, G.; Patrono, C.; van Kooten, V.; Koudstaal, I’. J. 1. 
Invest. Med. 1995, 43, Suppl. 2, 292A. 
26. Centado, J. J.; Adams, J.; Gross, M. L. Adv. Mass Spectrom. 
1989, ZZB, 1034-1035. 
27. Harrison, K. A.; Murphy, R. C. 7. Biol. Chem. 1995, 270, 
17273-17278. 
